Clinical Trial Update: Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports Phase 2 and Phase 3 results for risk-adapted allogeneic stem cell transplantation in non-malignant diseases with mixed donor chime…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Failure
• Combined Immunodeficiency
• Fanconi Anemia
• Osteopetrosis

Snippet

Sponsor: Columbia University | Conditions: Bone Marrow Failure, Osteopetrosis | Phase 2, Phase 3 | Status: COMPLETED